Literature DB >> 8348024

Dyspnea in dying patients.

D H Hsu1.   

Abstract

Dyspnea is common in terminally ill patients and is often fairly difficult to control. If specific causes cannot be identified or treated, general measures to relieve symptoms should be used. Nondrug measures (eg, discussion and explanation with the patient) and drug measures (eg, morphine) can be used to control the dyspnea, although side effects, such as sedation, can be problematic.

Entities:  

Mesh:

Year:  1993        PMID: 8348024      PMCID: PMC2379564     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  12 in total

1.  Dyspnea management: "to take into the air my quiet breath".

Authors:  P D Henteleff
Journal:  J Palliat Care       Date:  1989-12       Impact factor: 2.250

2.  Symptom control during the last week of life on a palliative care unit.

Authors:  R Fainsinger; M J Miller; E Bruera; J Hanson; T Maceachern
Journal:  J Palliat Care       Date:  1991       Impact factor: 2.250

3.  Symptom prevalence and control during cancer patients' last days of life.

Authors:  V Ventafridda; C Ripamonti; F De Conno; M Tamburini; B R Cassileth
Journal:  J Palliat Care       Date:  1990       Impact factor: 2.250

4.  Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life.

Authors:  N Coyle; J Adelhardt; K M Foley; R K Portenoy
Journal:  J Pain Symptom Manage       Date:  1990-04       Impact factor: 3.612

5.  Dyspnea in terminally ill cancer patients.

Authors:  D B Reuben; V Mor
Journal:  Chest       Date:  1986-02       Impact factor: 9.410

6.  Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases.

Authors:  A A Woodcock; E R Gross; A Gellert; S Shah; M Johnson; D M Geddes
Journal:  N Engl J Med       Date:  1981-12-31       Impact factor: 91.245

Review 7.  Dyspnea: physiological and pathophysiological mechanisms.

Authors:  K Wasserman; R Casaburi
Journal:  Annu Rev Med       Date:  1988       Impact factor: 13.739

8.  Continuous intravenous infusion of morphine for severe dyspnea.

Authors:  M H Cohen; A J Anderson; S H Krasnow; S V Spagnolo; M L Citron; M Payne; B E Fossieck
Journal:  South Med J       Date:  1991-02       Impact factor: 0.954

Review 9.  Assessment and management of breathlessness.

Authors:  M D Altose
Journal:  Chest       Date:  1985-08       Impact factor: 9.410

10.  Measuring symptoms in terminal cancer: are pain and dyspnoea controlled?

Authors:  I Higginson; M McCarthy
Journal:  J R Soc Med       Date:  1989-05       Impact factor: 18.000

View more
  2 in total

Review 1.  Preventing crises in palliative care in the home. Role of family physicians and nurses.

Authors:  G Howarth; K B Willison
Journal:  Can Fam Physician       Date:  1995-03       Impact factor: 3.275

2.  Clinical management of dying patients.

Authors:  J Gavrin; C R Chapman
Journal:  West J Med       Date:  1995-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.